摘要
我院1983~1992年共施行肾移植45例,应用常规免疫抑制剂3例,应用CSA三联用药42例,后者效果明显优于前者,急性排异率减少到40%,症状减轻,逆转容易,感染率降至21.4%,人肾一年存活率提高到91.4%。本文报道13例病人测定CSA谷值的作用及应用心痛定是预防肾毒性的有效性。
Abstract45 consecutive cases of allograft
transplantention was reported in our ho-spital from 1983 to 1992. 3 cases was used with routing
immune inhibitor,42cases used CsA-AzA-Pred. Better result was seen in latter,the incidence
ofacute rejection decreased to 40%with lighter symptom and easier recovery. Theincidence of
infection decreased to 21.4%. The survival rate of recipient andgraft for one year rose to
91.4%and 80%. The blood content of CsA wasestimated in 13 cases( 3 pairs).The function of this
test and the effectivenessof using nifidipine to prevert mephrotoxicity of CsA were discussed.
Key wores Renal transplantention CsA Nephrotoxity
出处
《云南医药》
CAS
1994年第6期416-419,共4页
Medicine and Pharmacy of Yunnan